Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1969 2
1970 1
1971 3
1972 5
1973 7
1974 2
1975 6
1976 1
1977 4
1978 3
1979 1
1980 1
1982 2
1984 3
1985 1
1986 1
1989 6
1990 1
1991 1
1992 1
1993 1
1994 1
1996 3
1997 1
2012 1
2013 1
2014 1
2015 1
2016 1
2019 1
2020 2
2021 1
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial.
Burmester GR, Buttgereit F, Bernasconi C, Álvaro-Gracia JM, Castro N, Dougados M, Gabay C, van Laar JM, Nebesky JM, Pethoe-Schramm A, Salvarani C, Donath MY, John MR; SEMIRA collaborators. Burmester GR, et al. Lancet. 2020 Jul 25;396(10246):267-276. doi: 10.1016/S0140-6736(20)30636-X. Lancet. 2020. PMID: 32711802 Clinical Trial.
Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial.
Koehm M, Rossmanith T, Foldenauer AC, Herrmann E, Brandt-Jürgens J, Burmester GR, Kellner H, Kiltz U, Kofler DM, Rech J, Mojtahed-Poor S, Jonetzko C, Burkhardt H, Behrens F; MUST Investigator Group. Koehm M, et al. Lancet Rheumatol. 2023 Jan;5(1):e14-e23. doi: 10.1016/S2665-9913(22)00329-0. Lancet Rheumatol. 2023. PMID: 38251504 Clinical Trial.
Ustekinumab Is Rapid-Acting and Is an Effective Long-Term Treatment for Patients with Active Psoriatic Arthritis: Real-World Evidence from the Non-interventional SUSTAIN Study.
Wendler J, Damann N, Röcken M, Teicher V, Schuier M, Hamann F, Schwenke H, Sieburg M, Behrens F. Wendler J, et al. Among authors: schwenke h. Rheumatol Ther. 2022 Oct;9(5):1435-1450. doi: 10.1007/s40744-022-00484-3. Epub 2022 Sep 6. Rheumatol Ther. 2022. PMID: 36066750 Free PMC article.
[Autoimmunity and autoaggression].
von Baehr R, Schwenke H. von Baehr R, et al. Among authors: schwenke h. Z Gesamte Inn Med. 1974 Apr 15;29(8):316-22. Z Gesamte Inn Med. 1974. PMID: 4605520 Review. German. No abstract available.
[Lymphocyte transformation as an allergy test].
Schwenke H, Raue I. Schwenke H, et al. Folia Haematol Int Mag Klin Morphol Blutforsch. 1971;96(1):21-8. Folia Haematol Int Mag Klin Morphol Blutforsch. 1971. PMID: 4110780 German. No abstract available.
Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial.
Koehm M, Foldenauer AC, Rossmanith T, Kellner H, Kiltz U, Burmester GR, Kofler DM, Brandt J, Finzel S, Bergner R, Sieburg M, Behrens F; MUST Investigator Group. Koehm M, et al. RMD Open. 2023 Dec 19;9(4):e003538. doi: 10.1136/rmdopen-2023-003538. RMD Open. 2023. PMID: 38114198 Free PMC article.
70 results